Ambulance administration of anti-clot drug may benefit heart attack patients

September 1, 2014 12:52 PM

1 0

Ambulance administration of the antiplatelet medication ticagrelor to patients with a type of heart attack known as ST segment elevation myocardial infarction (STEMI) is not better than hospital administration, in terms of improving blood flow in blocked arteries before a revascularisation procedure, according to a new study presented at ESC Congress 2014 today.

However, findings from the ATLANTIC (Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery) study show that the earlier administration of ticagrelor may prevent stent thrombosis - which is clotting within the tube (ste...

Read more

To category page

Loading...